244 related articles for article (PubMed ID: 37853331)
21. Transfusion medicine and the pregnant patient.
Lee AI; Kaufman RM
Hematol Oncol Clin North Am; 2011 Apr; 25(2):393-413, ix. PubMed ID: 21444037
[TBL] [Abstract][Full Text] [Related]
22. The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates.
Tyndall C; Cuzzilla R; Kane SC
Transfus Apher Sci; 2020 Oct; 59(5):102948. PubMed ID: 33008742
[TBL] [Abstract][Full Text] [Related]
23. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
24. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
25. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
26. Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.
Delaney M; Wikman A; van de Watering L; Schonewille H; Verdoes JP; Emery SP; Murphy MF; Staves J; Flach S; Arnold DM; Kaufman RM; Ziman A; Harm SK; Fung M; Eppes CS; Dunbar NM; Buser A; Meyer E; Savoia H; Abeysinghe P; Heddle N; Tinmouth A; Traore AN; Yazer MH;
Transfusion; 2017 Mar; 57(3):525-532. PubMed ID: 28164304
[TBL] [Abstract][Full Text] [Related]
27. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
[TBL] [Abstract][Full Text] [Related]
28. School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn.
Ree IMC; van 't Oever RM; Jansen L; Lopriore E; de Haas M; van Klink JMM
Early Hum Dev; 2021 Jun; 157():105381. PubMed ID: 33962361
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
30. A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
He Y; Gao W; Li Y; Xu C; Wang Q
Transfusion; 2023 Mar; 63(3):494-506. PubMed ID: 36727659
[TBL] [Abstract][Full Text] [Related]
31. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
Rahimi-Levene N; Chezar J; Yahalom V;
Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
[TBL] [Abstract][Full Text] [Related]
32. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
33. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
Trevett TN; Dorman K; Lamvu G; Moise KJ
Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
[TBL] [Abstract][Full Text] [Related]
34. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
[TBL] [Abstract][Full Text] [Related]
35. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
36. Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn.
Christensen RD; Bahr TM; Ohls RK; Ilstrup SJ; Moise KJ; Lopriore E; Meznarich JA
J Perinatol; 2024 Jun; 44(6):916-919. PubMed ID: 38216678
[TBL] [Abstract][Full Text] [Related]
37. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population.
Hassan MN; Mohd Noor NH; Johan Noor SR; Sukri SA; Mustafa R; Luc Aster HV
Asian J Transfus Sci; 2014 Jul; 8(2):113-7. PubMed ID: 25161351
[TBL] [Abstract][Full Text] [Related]
38. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
[TBL] [Abstract][Full Text] [Related]
39. Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.
Lu W; Ziman A; Yan MTS; Waters A; Virk MS; Tran A; Tang H; Shih AW; Scally E; Raval JS; Pandey S; Pagano MB; Shan H; Moore C; Morrison D; Cormack O; Fitzgerald J; Duncan J; Corean J; Clarke G; Yazer M
Transfusion; 2023 Apr; 63(4):817-825. PubMed ID: 36815517
[TBL] [Abstract][Full Text] [Related]
40. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
